Review
Copyright ©The Author(s) 2024.
World J Hepatol. May 27, 2024; 16(5): 688-702
Published online May 27, 2024. doi: 10.4254/wjh.v16.i5.688
Figure 2
Figure 2 Disruption of oral mucosal barriers by pathogenic microorganisms. Pathogenic microorganisms enhance Th17 cell secretion of interleukin (IL)-17 through stimulating factors, including IL-6 and IL-23, which leads to neutrophil aggregation and activation. Concurrently, oral epithelial cells reduce the expression of Claudin-1, Claudin-4, and E-cadherin, thereby increasing barrier permeability. This alteration elevates the risk of pathogenic microorganisms entering the bloodstream and reaching the liver. IL: Interleukin.